153 related articles for article (PubMed ID: 10818677)
1. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.
van der Voort R; Taher TE; Derksen PW; Spaargaren M; van der Neut R; Pals ST
Adv Cancer Res; 2000; 79():39-90. PubMed ID: 10818677
[TBL] [Abstract][Full Text] [Related]
2. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.
Birchmeier C; Gherardi E
Trends Cell Biol; 1998 Oct; 8(10):404-10. PubMed ID: 9789329
[TBL] [Abstract][Full Text] [Related]
3. The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.
Mahtouk K; Tjin EP; Spaargaren M; Pals ST
Biochim Biophys Acta; 2010 Dec; 1806(2):208-19. PubMed ID: 20655987
[TBL] [Abstract][Full Text] [Related]
4. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells.
Birchmeier W; Brinkmann V; Niemann C; Meiners S; DiCesare S; Naundorf H; Sachs M
Ciba Found Symp; 1997; 212():230-40; discussion 240-6. PubMed ID: 9524774
[TBL] [Abstract][Full Text] [Related]
5. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
Nakamura T
Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
[TBL] [Abstract][Full Text] [Related]
7. Targeting the hepatocyte growth factor/Met pathway in cancer.
De Silva DM; Roy A; Kato T; Cecchi F; Lee YH; Matsumoto K; Bottaro DP
Biochem Soc Trans; 2017 Aug; 45(4):855-870. PubMed ID: 28673936
[TBL] [Abstract][Full Text] [Related]
8. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
9. "Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection.
Bardelli A; Pugliese L; Comoglio PM
Biochim Biophys Acta; 1997 Dec; 1333(3):M41-51. PubMed ID: 9426201
[No Abstract] [Full Text] [Related]
10. [A simple view on lung cancer biology: the MET pathway].
Ruppert AM; Beau-Faller M; Belmont L; Lavolé A; Gounant V; Cadranel J; Wislez M
Rev Mal Respir; 2011 Dec; 28(10):1241-9. PubMed ID: 22152933
[TBL] [Abstract][Full Text] [Related]
11. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
To CT; Tsao MS
Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation.
Ariztia EV; Subbarao V; Solt DB; Rademaker AW; Iyer AP; Oltvai ZN
Exp Cell Res; 2003 Aug; 288(2):257-67. PubMed ID: 12915117
[TBL] [Abstract][Full Text] [Related]
13. Met, metastasis, motility and more.
Birchmeier C; Birchmeier W; Gherardi E; Vande Woude GF
Nat Rev Mol Cell Biol; 2003 Dec; 4(12):915-25. PubMed ID: 14685170
[No Abstract] [Full Text] [Related]
14. The biological role of HGF-MET axis in tumor growth and development of metastasis.
Lesko E; Majka M
Front Biosci; 2008 Jan; 13():1271-80. PubMed ID: 17981628
[TBL] [Abstract][Full Text] [Related]
15. HGF: a multifunctional growth factor controlling cell scattering.
Stella MC; Comoglio PM
Int J Biochem Cell Biol; 1999 Dec; 31(12):1357-62. PubMed ID: 10641789
[TBL] [Abstract][Full Text] [Related]
16. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.
Takayama H; LaRochelle WJ; Sharp R; Otsuka T; Kriebel P; Anver M; Aaronson SA; Merlino G
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):701-6. PubMed ID: 9012848
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor and c-Met (HGF/c-Met) in adenoid cystic carcinoma of the human salivary gland.
Suzuki K; Cheng J; Watanabe Y
J Oral Pathol Med; 2003 Feb; 32(2):84-9. PubMed ID: 12542830
[TBL] [Abstract][Full Text] [Related]
18. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
Derksen PW; de Gorter DJ; Meijer HP; Bende RJ; van Dijk M; Lokhorst HM; Bloem AC; Spaargaren M; Pals ST
Leukemia; 2003 Apr; 17(4):764-74. PubMed ID: 12682635
[TBL] [Abstract][Full Text] [Related]
19. The role of hepatocyte growth factor/c-met interactions in the immune system.
Skibinski G
Arch Immunol Ther Exp (Warsz); 2003; 51(5):277-82. PubMed ID: 14626426
[TBL] [Abstract][Full Text] [Related]
20. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
